annual EBITDA:
-$89.69M-$44.32M(-97.67%)Summary
- As of today (September 12, 2025), TRML annual EBITDA is -$89.69 million, with the most recent change of -$44.32 million (-97.67%) on December 31, 2024.
- During the last 3 years, TRML annual EBITDA has fallen by -$42.81 million (-91.31%).
- TRML annual EBITDA is now -398.32% below its all-time high of -$18.00 million, reached on December 1, 2019.
Performance
TRML EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$25.96M+$257.00K(+0.98%)Summary
- As of today (September 12, 2025), TRML quarterly EBITDA is -$25.96 million, with the most recent change of +$257.00 thousand (+0.98%) on June 30, 2025.
- Over the past year, TRML quarterly EBITDA has dropped by -$4.00 million (-18.22%).
- TRML quarterly EBITDA is now -460.01% below its all-time high of -$4.64 million, reached on June 1, 2020.
Performance
TRML quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$102.41M-$4.00M(-4.07%)Summary
- As of today (September 12, 2025), TRML TTM EBITDA is -$102.41 million, with the most recent change of -$4.00 million (-4.07%) on June 30, 2025.
- Over the past year, TRML TTM EBITDA has dropped by -$41.42 million (-67.93%).
- TRML TTM EBITDA is now -1997.62% below its all-time high of -$4.88 million, reached on March 1, 2020.
Performance
TRML TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
TRML EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -97.7% | -18.2% | -67.9% |
| 3 y3 years | -91.3% | -45.7% | -63.0% |
| 5 y5 years | -398.3% | -460.0% | -559.5% |
TRML EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -355.4% | at low | -298.0% | +1.0% | -176.6% | at low |
| 5 y | 5-year | -398.3% | at low | -332.1% | +1.0% | -559.5% | at low |
| alltime | all time | -398.3% | at low | -460.0% | +1.0% | -1997.6% | at low |
TRML EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$25.96M(-1.0%) | -$102.41M(+4.1%) |
| Mar 2025 | - | -$26.22M(+1.6%) | -$98.41M(+9.7%) |
| Dec 2024 | -$89.69M(+97.7%) | -$25.80M(+5.6%) | -$89.69M(+13.9%) |
| Sep 2024 | - | -$24.43M(+11.2%) | -$78.78M(+29.2%) |
| Jun 2024 | - | -$21.96M(+25.4%) | -$60.98M(+10.1%) |
| Mar 2024 | - | -$17.51M(+17.7%) | -$55.39M(+22.1%) |
| Dec 2023 | -$45.38M(+130.4%) | -$14.88M(+124.3%) | -$45.38M(+22.6%) |
| Sep 2023 | - | -$6.63M(-59.5%) | -$37.02M(-25.0%) |
| Jun 2023 | - | -$16.37M(+118.3%) | -$49.38M(-2.9%) |
| Mar 2023 | - | -$7.50M(+14.9%) | -$50.83M(-17.0%) |
| Dec 2022 | -$19.70M | - | - |
| Dec 2022 | - | -$6.52M(-65.7%) | -$61.26M(-11.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$18.99M(+6.6%) | -$68.94M(+9.7%) |
| Jun 2022 | - | -$17.82M(-0.6%) | -$62.84M(+12.3%) |
| Mar 2022 | - | -$17.93M(+26.2%) | -$55.94M(+19.3%) |
| Dec 2021 | -$46.88M(+110.8%) | -$14.20M(+10.2%) | -$46.88M(+19.0%) |
| Sep 2021 | - | -$12.89M(+18.0%) | -$39.39M(+21.2%) |
| Jun 2021 | - | -$10.92M(+23.2%) | -$32.51M(+24.0%) |
| Mar 2021 | - | -$8.87M(+32.2%) | -$26.23M(+17.9%) |
| Dec 2020 | -$22.24M(+23.5%) | -$6.71M(+11.7%) | -$22.24M(+43.2%) |
| Sep 2020 | - | -$6.01M(+29.6%) | -$15.53M(+63.1%) |
| Jun 2020 | - | -$4.64M(-5.0%) | -$9.52M(+95.0%) |
| Mar 2020 | - | -$4.88M | -$4.88M |
| Dec 2019 | -$18.00M | - | - |
FAQ
- What is Tourmaline Bio, Inc. annual EBITDA?
- What is the all time high annual EBITDA for Tourmaline Bio, Inc.?
- What is Tourmaline Bio, Inc. annual EBITDA year-on-year change?
- What is Tourmaline Bio, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Tourmaline Bio, Inc.?
- What is Tourmaline Bio, Inc. quarterly EBITDA year-on-year change?
- What is Tourmaline Bio, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Tourmaline Bio, Inc.?
- What is Tourmaline Bio, Inc. TTM EBITDA year-on-year change?
What is Tourmaline Bio, Inc. annual EBITDA?
The current annual EBITDA of TRML is -$89.69M
What is the all time high annual EBITDA for Tourmaline Bio, Inc.?
Tourmaline Bio, Inc. all-time high annual EBITDA is -$18.00M
What is Tourmaline Bio, Inc. annual EBITDA year-on-year change?
Over the past year, TRML annual EBITDA has changed by -$44.32M (-97.67%)
What is Tourmaline Bio, Inc. quarterly EBITDA?
The current quarterly EBITDA of TRML is -$25.96M
What is the all time high quarterly EBITDA for Tourmaline Bio, Inc.?
Tourmaline Bio, Inc. all-time high quarterly EBITDA is -$4.64M
What is Tourmaline Bio, Inc. quarterly EBITDA year-on-year change?
Over the past year, TRML quarterly EBITDA has changed by -$4.00M (-18.22%)
What is Tourmaline Bio, Inc. TTM EBITDA?
The current TTM EBITDA of TRML is -$102.41M
What is the all time high TTM EBITDA for Tourmaline Bio, Inc.?
Tourmaline Bio, Inc. all-time high TTM EBITDA is -$4.88M
What is Tourmaline Bio, Inc. TTM EBITDA year-on-year change?
Over the past year, TRML TTM EBITDA has changed by -$41.42M (-67.93%)